Furthermore, enhanced CDX2 promoter methylation is associated with gene silencing in a subgroup of colorectal cancer patients with lymph node metastasis and shorter survival times (118). The gene discussed is CDX2; the disease is metastatic malignant neoplasm in the lymph nodes.